The global vitamin ingredients market is undergoing a fundamental transformation — not just in scale, but in structure. The era of "volume-driven" commodity supply is giving way to a "value-driven" era defined by application diversification, supply chain realignment, and scientific repositioning of established ingredients.

Understanding this shift is critical for procurement professionals, formulators, and business strategists. This article synthesizes the latest market data, emerging research, and industry trends to provide a comprehensive overview of where the vitamin market is heading — and what it means for your business.

I. Market Size and Growth Trajectory: The Numbers Behind the Shift

The global food-grade vitamins and mineral premixes market was valued at approximately USD 8.8 billion in 2024 and is projected to reach USD 12.74 billion by 2031, growing at a CAGR of 5.50% . Meanwhile, the broader vitamin B complex ingredients market, valued at USD 3.6 billion in 2025, is expected to reach USD 5.2 billion by 2034 at a CAGR of 4.1% .

Two key observations:

1. Feed applications still dominate volume. Animal feed additives account for approximately 42.8% of vitamin B complex ingredient consumption, driven by global livestock production and the shift toward antibiotic-free animal production .
2. Human nutrition and personal care are driving value growth. The fastest-growing segments are in dietary supplements, nutricosmetics, and functional foods — where ingredient differentiation and formulation innovation command premium pricing .

II. The Industry Is Restructuring: Supply Realignment and Strategic Divestments

Between 2025 and early 2026, the global vitamin ingredient industry experienced significant consolidation and realignment .

dsm-firmenich divested its Feed Enzymes Alliance stake to Novonesis for €1.5 billion (2025) and in February 2026 agreed to divest its entire Animal Nutrition & Health business to CVC Capital Partners for €2.2 billion .

BASF completed the sale of its Food and Health Performance Ingredients business to Louis Dreyfus Company in September 2025, refocusing on core vitamin value chains . In January 2026, BASF lifted all remaining force majeure declarations related to prior production disruptions, restoring supply stability .

What this means for buyers:

Major producers are prioritizing high-margin human nutrition and specialty applications over commodity feed-grade supply. This creates both challenges (potential tightening of feed-grade supply) and opportunities (increased innovation in specialty grades for supplements, cosmetics, and pharmaceuticals).

III. Application Trends: Where Growth Is Happening

3.1 Animal Feed: The Foundation — and a Changing Landscape

Feed additives remain the largest application segment, accounting for 42.8% of vitamin B complex consumption . However, the nature of demand is shifting:

• Antibiotic-free production is driving increased reliance on optimized vitamin supplementation to support immune function .
• Precision nutrition is gaining traction, with vitamins like niacinamide being studied for specific functional benefits beyond deficiency prevention — such as improving antioxidant status and intestinal health in pigs fed low-protein diets .

3.2 Dietary Supplements and Nutricosmetics: The Value Driver

Supplements and nutricosmetics represent the fastest-growing segment, fueled by consumer demand for:

• Healthy aging: Niacin (Vitamin B3) is being repositioned due to its role as a NAD⁺ precursor, with applications in cellular energy metabolism, DNA repair, and metabolic health .
• Cognitive health: Vitamins B6, B9, and B12 are gaining recognition as evidence-backed neuroprotective agents .
• Beauty-from-within: Vitamin B7 (biotin) and B3 (niacinamide) are increasingly combined in premium nutricosmetic formulations .

Niacinamide (Vitamin B3) holds a 24.8% share of the vitamin B complex ingredients market in 2025, driven by both feed fortification and expanding skincare applications where its skin-brightening, anti-aging, and barrier-enhancing properties drive demand .

3.3 Cosmetics and Personal Care: The Premium Frontier

Coenzyme Q10 (CoQ10) is gaining significant traction in cosmetics due to its antioxidant properties and ability to combat visible signs of aging. It works by neutralizing free radicals that accelerate aging, reducing fine lines and wrinkles while improving skin texture and tone .

The ubiquinone form dominated the CoQ10 market in 2024, accounting for 59.8% share, due to its widespread availability, affordability, and stable manufacturing characteristics .

IV. Emerging Research: Repositioning Established Ingredients

Recent scientific findings are creating new narratives for established vitamin ingredients:

Niacinamide (Vitamin B3)

Research published in 2025 demonstrated that dietary supplementation with 130 mg/kg niacinamide in finishing pigs fed low-protein diets improved antioxidant enzyme activities, reduced oxidative stress, modulated inflammatory responses, and promoted intestinal microbial balance . Beyond animal nutrition, niacinamide's role as an NAD⁺ precursor is driving its repositioning in healthy aging and metabolic health formulations.

Vitamin C (Ascorbic Acid)

Ascorbic acid has received GRAS (Generally Recognized as Safe) status from the FDA for use as a chemical preservative, nutritional fortifier, and dough conditioner, with specific use limits in various food applications (e.g., flour, canned fruits, meats) . In poultry nutrition, ascorbic acid supplementation improves heat stress resilience, immunity, and eggshell quality .

Coenzyme Q10

The global CoQ10 market is projected to grow from USD 710 million in 2024 to USD 2 billion by 2034, driven by increasing awareness of preventive healthcare and the growing use of CoQ10 in pharmaceuticals, cosmetics, and functional foods . The pharmaceutical-grade segment held 45.2% share in 2024 and is expected to grow at an 11% CAGR .

V. Implications for Procurement and Product Development

For Feed and Food Manufacturers

• Supply stability requires monitoring global production shifts, particularly in China where production restrictions caused Vitamin B1 and B6 prices to nearly double in 2024-2025 before stabilizing .
• Functional differentiation is emerging as a competitive advantage. Niacinamide's demonstrated benefits beyond deficiency prevention (e.g., antioxidant and gut health effects)  suggest opportunities for premium feed formulations.

For Supplement and Cosmetic Brands

• NAD⁺-related nutrition is a high-growth frontier. Niacinamide and nicotinic acid are being repositioned as cellular health actives, not just vitamins.
• Bioavailability innovation is critical. Lipid-based and encapsulated delivery systems can improve absorption efficiency by 30–40% for B-vitamins .
• Plant-based fortification represents a structural demand driver, with Vitamin B12 considered a "parity nutrient" for alternative proteins .

For Procurement Professionals

• Supplier qualification must now include assessment of application-specific capabilities — not just purity and price, but formulation support, stability data, and regulatory documentation.
• Strategic sourcing should consider both commodity supply stability (feed-grade) and value-added innovation (pharma/cosmetic grade).

VI. Conclusion: From Volume to Value

The vitamin ingredients market is not declining — it is evolving.

• Commodity segments (feed-grade, large-volume) will continue to grow with global protein demand.
• Specialty segments (pharma-grade, cosmetic-grade, NAD⁺ nutrition) will grow faster, driven by innovation, science, and consumer awareness.
• Procurement strategies must adapt — moving from "lowest price" to "best value" based on application support, quality documentation, and supply chain reliability.

Chinese vitamin manufacturers account for a significant share of global capacity, and the industry is shifting from "scale-driven" to "value-driven" operations. Companies that invest in product definition, application validation, and regulatory compliance are best positioned to capture the premium segments of the market.

E-mail:
yolanda@liyinbio.com

TEL: 
+86-15824830539

Address:
Zhengzhou, China